DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients?

Jason A. Roberts, Sanjoy K. Paul, Murat Akova, Matteo Bassetti, Jan J. De Waele, George Dimopoulos, Kirsi Maija Kaukonen, Despoina Koulenti, Claude Martin, Philippe Montravers, Jordi Rello, Andrew Rhodes, Therese Starr, Steven C. Wallis, Jeffrey Lipman, Antonio Margarit Ribas, Luc De Crop, Herbert Spapen, Joost Wauters, Thierry DugernierPhilippe Jorens, Ilse Dapper, Daniel De Backer, Fabio S. Taccone, Laura Ruano, Elsa Afonso, Francisco Alvarez-Lerma, Maria Pilar Gracia-Arnillas, Francisco Fernández, Neus Feijoo, Neus Bardolet, Assumpta Rovira, Pau Garro, Diana Colon, Carlos Castillo, Juan Fernado, Maria Jesus Lopez, Jose Luis Fernandez, Ana Maria Arribas, Jose Luis Teja, Elsa Ots, Juan Carlos Montejo, Mercedes Catalan, Isidro Prieto, Gloria Gonzalo, Beatriz Galvan, Miguel Angel Blasco, Estibaliz Meyer, Frutos Del Nogal, Loreto Vidaur, Rosa Sebastian, Pila Marco Garde, Maria Del Mar Martin Velasco, Rafael Zaragoza Crespo, Mariano Esperatti, Antoni Torres, Olivier Baldesi, Herve Dupont, Yazine Mahjoub, Sigismond Lasocki, Jean Michel Constantin, Jean François Payen, Jacques Albanese, Yannick Malledant, Julien Pottecher, Jean Yves Lefrant, Samir Jaber, Olivier Joannes-Boyau, Christophe Orban, Marlies Ostermann, Cathrine McKenzie, William Berry, John Smith, Katie Lei, Francesca Rubulotta, Anthony Gordon, Stephen Brett, Martin Stotz, Maie Templeton, Claudia Ebm, Carl Moran, Ville Pettilä, Aglaia Xristodoulou, Vassiliki Theodorou, Georgios Kouliatsis, Eleni Sertaridou, Georgios Anthopoulos, George Choutas, Thanos Rantis, Stylianos Karatzas, Margarita Balla, Metaxia Papanikolaou, Pavlos Myrianthefs, Alexandra Gavala, Georgios Fildisis, Antonia Koutsoukou, Magdalini Kyriakopoulou, Kalomoira Petrochilou, Maria Kompoti, Martha Michalia, Fillis Maria Clouva-Molyvdas, Georgios Gkiokas, Fotios Nikolakopoulos, Vasiliki Psychogiou, Polychronis Malliotakis, Evangelia Akoumianaki, Emmanouil Lilitsis, Vassilios Koulouras, George Nakos, Mihalis Kalogirou, Apostolos Komnos, Tilemachos Zafeiridis, Christos Chaintoutis, Kostoula Arvaniti, Dimitrios Matamis, Christina Kydona, Nikoleta Gritsi-Gerogianni, Tatiana Giasnetsova, Maria Giannakou, Ioanna Soultati, Ilias Chytas, Eleni Antoniadou, Elli Antipa, Dimitrios Lathyris, Triantafyllia Koukoubani, Theoniki Paraforou, Kyriaki Spiropoulou, Vasileios Bekos, Anna Spring, Theodora Kalatzi, Hara Nikolaou, Maria Laskou, Ioannis Strouvalis, Stavros Aloizos, Spyridon Kapogiannis, Ourania Soldatou, Chiara Adembri, Gianluca Villa, Antonio Giarratano, Santi Maurizio Raineri, Andrea Cortegiani, Francesca Montalto, Maria Teresa Strano, V. Marco Ranieri, Claudio Sandroni, Gennaro De Pascale, Alexandre Molin, Paolo Pelosi, Luca Montagnani, Rosario Urbino, Ilaria Mastromauro, Francesco G. De Rosa, Teresa Cardoso, Susana Afonso, João Gonçalves-Pereira, João Pedro Baptista, Arife Özveren

Research output: Contribution to journalArticle

Abstract

Background. Morbidity and mortality for critically ill patients with infections remains a global healthcare problem. We aimed to determine whether α-lactam antibiotic dosing in critically ill patients achieves concentrations associated with maximal activity and whether antibiotic concentrations affect patient outcome.Methods. This was a prospective, multinational pharmacokinetic point-prevalence study including 8 α-lactam antibiotics. Two blood samples were taken from each patient during a single dosing interval. The primary pharmacokinetic/pharmacodynamic targets were free antibiotic concentrations above the minimum inhibitory concentration (MIC) of the pathogen at both 50% (50% f TMIC) and 100% (100% f T MIC) of the dosing interval. We used skewed logistic regression to describe the effect of antibiotic exposure on patient outcome.Results. We included 384 patients (361 evaluable patients) across 68 hospitals. The median age was 61 (interquartile range [IQR], 48-73) years, the median Acute Physiology and Chronic Health Evaluation II score was 18 (IQR, 14-24), and 65% of patients were male. Of the 248 patients treated for infection, 16% did not achieve 50% f TMIC and these patients were 32% less likely to have a positive clinical outcome (odds ratio [OR], 0.68; P =. 009). Positive clinical outcome was associated with increasing 50% f TMIC and 100% f TMIC ratios (OR, 1.02 and 1.56, respectively; P

Original languageEnglish (US)
Pages (from-to)1072-1083
Number of pages12
JournalClinical Infectious Diseases
Volume58
Issue number8
DOIs
StatePublished - Apr 15 2014
Externally publishedYes

    Fingerprint

Keywords

  • adverse events
  • continuous infusion
  • extended infusion
  • pharmacodynamics
  • pharmacokinetics

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)
  • Medicine(all)

Cite this

Roberts, J. A., Paul, S. K., Akova, M., Bassetti, M., De Waele, J. J., Dimopoulos, G., Kaukonen, K. M., Koulenti, D., Martin, C., Montravers, P., Rello, J., Rhodes, A., Starr, T., Wallis, S. C., Lipman, J., Margarit Ribas, A., De Crop, L., Spapen, H., Wauters, J., ... Özveren, A. (2014). DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients? Clinical Infectious Diseases, 58(8), 1072-1083. https://doi.org/10.1093/cid/ciu027